An exploratory randomized controlled study of qianma Zhisou granule in the treatment of cough after infectio
- Conditions
- Cough after infection
- Registration Number
- ITMCTR2200006030
- Lead Sponsor
- The First Affiliated Hospital of Henan University of traditional Chinese Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- Not specified
? It is consistent with the diagnosis of cough after infection by traditional Chinese and Western medicine;
? Course of disease = 3 weeks and < 8 weeks;
? Those aged = 18 and = 60;
? The subjects were informed and voluntarily signed the informed consent form.
? Allergic to known traditional Chinese medicine ingredients;
? Patients with unstable angina pectoris, acute myocardial infarction, resting pulmonary artery pressure > 45mmhg, cardiac function grade 2 and above;
? Combined with some chronic diseases, such as chronic obstructive pulmonary disease, bronchial asthma, cough variant asthma, reflux esophagitis, chronic pharyngitis, etcIrritable cough;
? Severe liver and kidney disease (severe liver disease refers to liver cirrhosis, portal hypertension and variceal bleeding. Severe kidney disease includes dialysis and kidney transplantation)
? Pregnant or preparing pregnant women, lactating women;
? Those who have participated in clinical trials of other drugs in recent 1 month;
? Patients with purulent sputum or suppurative tonsillitis;
? Patients with dementia and various mental diseases;
? Those who are participating in clinical trials of other interventions.
Study & Design
- Study Type
- Interventional study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Cough symptom score;
- Secondary Outcome Measures
Name Time Method Quality of life evaluation of cough;Visual analogue scale (VAS);TCM syndrome score;Clinical effective rate;Cough relief and disappearance time;